SCHEMBL16628685

SCHEMBL16628685

CS(=O)(=O)Nc1ccc(CCNC(=O)c2nc(N)nc3ccccc23)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.54
ADORA1 P30542 2/20 0.54
SLC6A3 Q01959 1/20 0.54
ADORA3 P0DMS8 5/20 0.54
GSK3B P49841 3/20 0.51
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM1A O60341 1/20 0.47
LMNA P02545 1/20 0.47
RECQL P46063 1/20 0.47
ADORA2B P29275 1/20 0.47
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16628768 0.89 ADORA2A (0.54) ADORA2AADORA1SLC6A3ADORA3CYP1A2
SCHEMBL3081056 0.86 ADORA2A (0.70) ADORA2AADORA1ADORA3ALDH1A1LMNA
SCHEMBL16628795 0.85 ADORA3 (0.66) ADORA2AADORA1ADORA3CASP1KDM4E
SCHEMBL3087954 0.83 ADORA2A (0.66) ADORA2AADORA1ADORA3ALDH1A1ADORA2B
SCHEMBL16628820 0.82 ADORA3 (0.68) ADORA2AADORA1ADORA3CYP1A2CYP2D6
SCHEMBL3093862 0.80 ADORA2A (0.62) ADORA2AADORA1ADORA3KDM4EALDH1A1
SCHEMBL13144381 0.80 ADORA3 (0.47) SLC6A3ADORA3CYP1A2CYP2D6CYP2C9
SCHEMBL3087918 0.79 ADORA3 (0.62) ADORA2AADORA1ADORA3CYP1A2CYP2D6
SCHEMBL16628733 0.78 ADORA2A (0.59) ADORA2AADORA1ADORA3ALDH1A1LMNA
SCHEMBL16628808 0.77 ADORA2A (0.55) ADORA2AADORA1ADORA3CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP claimed